Curriculum Vitae (2023)
`
`Eugene Edward Wright, Jr. MD
`4132 Stacy Blvd
`Charlo3e, NC 28209
`eewright51@gmail.com
`
`Medical Director, Performance Improvement South Piedmont Area Health EducaLon Center (AHEC)
`Charlo3e, NC
`
`
`
`
`
`
`
`
`
`2019 -
`
`ConsulLng Associate Department of Medicine and Department of Community and Family Medicine Duke
`University Southern Regional Area Health EducaLon Center (AHEC), Faye3eville, NC.
`Associate Professor Campbell University School of Osteopathic Medicine (CUSOM)
`2013 –
`
`Clinician and Diabetologist for The Care Clinic, Faye3eville, NC
`The CARE Clinic provides free quality health care to eligible uninsured, low-income adults who live in
`Cumberland County and surrounding areas. I serve as the primary care provider for paLents with dia-
`betes as one of their condiLons.
`
`
`
`
`
`2013 - 2018
`
`2013- 2016
`
`
`
`Cape Fear Valley Health System, Faye3eville, NC
`Sr. Advisor for Medical Affairs - Serve as advisor to CEO, CMO and Associate Medical Director of Primary
`Care PracLces and serve as health system liaison to Campbell University School of Medicine (CUSOM), a
`new Osteopathic School of Medicine in North Carolina.
`
`Chief Medical Officer and Medical Director for Primary Care and Specialty PracLces
`2011-2013
`System ResponsibiliLes for medical staff affairs including credenLaling, quality, safety and uLlizaLon
`management across a medical staff of over 550 pracLLoners at 5 hospitals
`
`
`Cape Fear Valley Health System, Faye3eville, NC
`Medical Director for Primary Care and Specialty PracLces
`Accountable for 16 physician groups comprised of Family and Internal Medicine, Pediatric, Geriatric, En-
`docrinology, InfecLons Disease, Gynecology and Hospitalist. Coordinates clinical and pracLce manage-
`ment acLviLes for approximately 48 primary care providers in 12 pracLces and 12 specialists in three
`specialty pracLces.
`
`
`
`
`
`
`
` 2000 – 2011
`
`SELECTED ACCOMPLISHMENTS
`
`➢ Helped lead Cape Fear Valley Medical Center to become naLonally-recognized health system earning
`numerous quality awards, including:
`o 23 Hospital Quality IncenLve DemonstraLon (HQID) awards from the Centers for Medicare
`and Medicaid Services (CMS)
`o Numerous QUEST awards as a Top Performing Hospital
`o 3 Star RaLng in Cardiac Surgery, pudng us in the top 15% in the naLon
`o Chest Pain Center AccreditaLon
`o Joint Commission Disease Specific CerLficaLon in Hip & Knee replacement surgery
`o Joint Commission Disease Specific CerLficaLon in heart failure
`o Joint Commission Disease Specific CerLficaLon in stroke
`
`ABBOTT Exhibit 2014, Page 1 of 11
`Dexcom, Inc. v. Abbott Diabetes Care Inc.
`IPR2023-01251
`
`

`

`o Ranking #1 in N.C. for Vascular services, as reported in Business North Carolina
`o Ranking in the top 10 statewide for Cardiology Services, Pulmonary, Overall Cardiac Services,
`Coronary IntervenLonal Procedures, Bariatric Surgery and CriLcal Care Services
`
`➢ IniLally charged with overhauling the network of primary care pracLces owned and operated by
`CFVHS. The overhaul included a restructuring of incenLves and compensaLon. In FY 2000 the
`health system employed ~45 primary care pracLLoners in 14 pracLce sites with approximately
`130,000 encounters per year. By 2007, grown network to 68 pracLLoners in 15 pracLces and
`200,000 encounters per year. Also added pracLces in and Geriatrics, Acute and LTACH, OB/GYN,
`Perinatology, Neurology, Neurosurgery, Urology and Trauma.
`
`
`➢ In 2002, tasked with developing a program with affiliate, Faye3eville State University (FSU)
`School of Business, designed to serve health system employees seeking to obtain formal educa-
`Lon in management and also to provide a reservoir of applicants for health system’s manage-
`ment posiLons. Over an 18-month period, in collaboraLon with a core group of VPs and direc-
`tors and representaLves from the FSU School of Business, developed a curriculum, and inter-
`viewed applicants for the MBA faculty program with a health care concentraLon. The first class
`graduated in May of 2007.
`
`➢ In 2002, selected by the CEO to represent CFVHS on the Faye3eville Chamber of Commerce serv-
`ing as Chair of the Finance Commi3ee and parLcipated in the formaLon of the Cumberland
`County Business Council.
`
`➢ Accountable for physician recruitment with the support of a recruiter and a staff assistant; over a
`four year period, successfully recruited more than120 pracLLoners across mulLple specialLes to
`the community and health system.
`
`➢ As a part of the Physician SaLsfacLon Task Force, led and implemented a Physician AcLon Line
`(PAL) as a service recovery / physician loyalty tool. This has been presented at the Press Ganey
`saLsfacLon conference and at the PRC NaLonal Conference in Orlando in 2004.
`
`➢ ReconsLtuted Hospitalist program from ONE physician in January 2001 with an ADC of 15-20
`between two faciliLes to a program of 18 physicians and two PA’s with an ADC of 175 between
`two faciliLes
`
`➢ During the capital campaign of the Cape Fear Valley Diabetes Center, provided technical as-
`sistance and resource to the grant writer to procure >$750K of grant funding for the center.
`
`PREVIOUS EXPERIENCE
`
`DUKE UNIVERSITY DEPARTMENT OF COMMUNITY AND FAMILY MEDICINE 2014 - 2020
`ConsulLng Associate in Department of Community and Family Medicine 2014 - 2020
`
`DUKE UNIVERSITY MEDICAL CENTER DEPARTMENT OF MEDICINE, Durham, NC 1996 - PRESENT
`ConsulLng Associate in Department of Medicine
`2000 - PRESENT
`
`
`
`ABBOTT Exhibit 2014, Page 2 of 11
`Dexcom, Inc. v. Abbott Diabetes Care Inc.
`IPR2023-01251
`
`

`

`
`
`1996 - 2000
`
`Associate in Division of General Medicine
`Three primary areas of responsibility:
`Primary care provide for a panel of approximately 3000 paLents
`-
`Taught medical students and residents rotaLng through the internal medicine program
`-
`Development of Minority Faculty Development Program and parLcipant in the Center for
`-
`Clinical Research in Minority PopulaLon at the Duke Clinical Research InsLtute
`
`
`
`
`
`
`INTEGRATED PROVIDER NETWORK OF COSTAL PHYSICIAN GROUPS, Durham, NC 1995 - 1996
`Senior Vice President for Medical OperaLons and Medical Director
`Responsible for clinical operaLons of six clinic sites in the Raleigh-Durham area including budget and
`revenues
`
`MEDICAL REVIEW OF NORTH CAROLINA
`Reviewer
`Performed reviews for the Peer Review OrganizaLon for the state of North Carolina. These reviews were
`focused on the uLlizaLon of resources and quality of care of the providers and hospitals
`
`CUMBERLAND INTERNAL MEDICINE, PA Faye3eville, NC
`Founder and President of Internal Medicine Group
`Launched a solo pracLce that evolved into a four-physician pracLce of general internal medicine
`
`
`
` 1983 - 1994
`
`
`
`1981 - 1995
`
`
`
`
`
`
`
`
`
`POST GRADUATE TRAINING
`
` Duke University Medical Center, Durham, NC
` Intern, Department of Medicine - JULY 1978 TO JUNE 1979
`
`
` Junior Assistance Resident - JULY 1979 TO JUNE 1980
` Department of Medicine
`
` Senior Assistant Resident - JULY 1980 TO JUNE 1981
` Department of Medicine
`
`EDUCATION
`
`Princeton University, Princeton, NJ
`BSE, Electrical Engineering, June 1973
`
`Duke University School of Medicine, Durham, NC
`MD in Medicine, June 1978
`
`
`LICENSURE AND CERTIFICATIONS
`
`➢ North Carolina Board of Medical Examiners – Licensed to pracLce in the state of North Carolina
`December 1979 NC23990 (ACTIVE)
`➢ American Board of Internal Medicine – Board cerLfied in Internal Medicine, September 1983
`
`ABBOTT Exhibit 2014, Page 3 of 11
`Dexcom, Inc. v. Abbott Diabetes Care Inc.
`IPR2023-01251
`
`

`

`PROFESSIONAL SOCIETIES
`
`North Carolina Medical Society, Member
`American Diabetes AssociaLon, Member
`American College of Diabetology
`
`OFFICES
`
`Student NaLonal Medical AssociaLon
`➢ 1976-1978 Chairman, Board of Directors
`➢ 1975-1976 Regional Director
`➢ 1974-1978 Member
`
`COMMITTEES
`
`10/2018 to 6/2020
`CHAIR OF THE ADA PRIMARY CARE INTEREST GROUP
`-
`
`8/2009 to 2022
`PLANNING COMMITTEE OF THE CLINICAL CONFERENCE OF THE ADA (formerly the Southern
`-
`Regional Conference)
`CO CHAIR 2012, 2013 AND 2019
`
`-
`
`11/1998 to 3/2005
`DUKE UNIVERSITY MEDICAL ALUMNI ASSOCIATION COUNCIL MEMBER
`-
`
`6/1995 to 12/2006
`- WILDACRES LEADERSHIP INITIATIVE
`- MEMBER OF THE WILLIAM C. FRIDAY FELLOWSHIP FOR HUMAN RELATIONS BOARD OF ADVI-
`SORS AND SELECTION COMMITTEE
`3/1995 to 10/1995
`- UNIVERSITY OF NORTH CAROLINA AHEC DIRECTOR SEARCH COMMITTEE MEMBER
`
`1990 to 1991
`THE UNIVERSITY OF NORTH CAROLINA BOARD OF GOVERNORS MEDICAL DENTAL SCHOLAR-
`-
`SHIP SELECTION COMMITTEE
`
`1989 to 1990
`- UNIVERSITY OF NORTH CAROLINA AT WILMINGTON
`- MEMBER OF THE CHANCELLOR SEARCH COMMITTEE
`
`1987 - 1995 HIGHSMITH RAINEY MEMORIAL HOSPITAL
`1987 - 1995 TRUSTEE
`1987 - 1989 CHIEF OF STAFF
`1986 - 1988 Secretary/Treasurer, FIFTH DISTRICT MEDICAL SOCIETY OF THE NCMS
`
`1982 to 1995 - CHAIR AND MEMBER OF SEVERAL HOSPITAL MEDICAL STAFF COMMITTEES AT CAPE FEAR
`VALLEY MEDICAL CENTER AND HIGHSMITH RAINEY MEMORIAL HOSPITAL INCLUDING INFECTION CON-
`TROL, ICU/CCU COMMITTEE, UTILIZATION REVIEW COMMITTEE, CREDENTIALS COMMITTEE, SECRETARY
`OF THE INTERNAL MEDICINE SECTION AND SECRETARY OF THE MEDICAL STAFF.
`
`ABBOTT Exhibit 2014, Page 4 of 11
`Dexcom, Inc. v. Abbott Diabetes Care Inc.
`IPR2023-01251
`
`

`

`UNIVERSITY OF NORTH CAROLINA AT WILMINGTON
`➢ 7/84-6/95 Trustee and Chair of Student Affairs and Academic Affairs
`➢ 7/94-6/95 Chairman, Board of Trustees & Endowment Board
`
`1977 to 1979
`BLACK HEALTH PROVIDERS TASK FORCE ON HIGH BLOOD PRESSURE
`- NATIONAL INSTITUTES OF HEALTH TASK FORCE ON HYPERTENSION DETECTION EDUCATION
`AND CONTROL IN THE BLACK COMMUNITY
`
`
`ADVISORY BOARDS
`
`➢ EDITORIAL BOARD FOR CLINICAL DIABETES 2002-2004, 2017 - PRESENT
`➢ ASSOCIATE EDITOR FOR CLINICAL DIABETES 2022- PRESENT
`➢ EDITORIAL BOARD FOR DIABETES TECHNOLOGY & THERAPEUTICS 2020 - PRESENT
`➢ ABBOTT DIABETES CARE PRIMARY CARE AND ENDOCRINE ADVISORY BOARD 2010-PRESENT
`➢ ADA/AHA DIABETES & CARDIOVASCULAR DISEASE SCIENCE ADVISORY GROUP 2018 – PRESENT
`➢ BAYER CARDIORENAL PRIMARY CARE ADVISORY BOARD 2019 – PRESENT
`➢ BAYER RENOVATE ADVISORY BOARD MEMBER 2020-PRESENT
`➢ GLOBAL KIDNEY DISEASE EXPERT SUMMIT PRIMARY CARE FORUM CO CHAIR
`➢ BOEHRINGER INGELHEIM CARDIORENAL ADVISORY BOARD 2020-PRESENT
`➢ SANOFI TOUJEO PUBLICATION ADVISORY BOARD 2018 – PRESENT
`➢ SANOFI TOUJEO PRIMARY CARE ADVISORY BOARD 2019 - PRESENT
`➢ SANOFI SOLIQUA ADVISORY BOARD 2018 - 2020
`➢ UPTODATE ENDOCRINOLOGY AND DIABETES PEER REVIEWER 2009 – PRESENT
`➢ VOLUNTIS SCIENTIFIC ADVISORY BOARD 2015 – 2020
`➢ LILLY GLOBAL PRIMARY CARE ADVISORY BOARD 2011 – 2018
`➢ BOEHRINGER INGELHEIM PHARMACEUTICAL, INC PRIMARY CARE ADVISORY BOARD 2010-2020
`➢ NOVO NORDISK PRIMARY CARE ADVISORY BOARD 2006 – 2009
`➢ INSULIN CONGRESS STEERING COMMITTEE 2006
`➢ EYETEL MEDICAL SCIENTIFIC ADVISORY BOARD 2004 -2006
`2004-2008
`➢ EDITORIAL BOARD FOR DOC NEWS
`➢ EDITORIAL BOARD FOR InforMed on Diabetes 2004
`➢ LILLY-AMYLIN PRIMARY CARE ADVISORY BOARD 2003 – 2011
`➢ ELI LILLY NORTH AMERICAN DIABETES ADVISORY BOARD 1998 -2011
`➢ RENALYTIX HCP ADVISORY BOARD 2023-PRESENT
`➢ EMBECTA HCP ADVISORY BOARD 2023-PRESENT
`
`
`
`AWARDS
`
`THE UNIVERSITY OF NORTH CAROLINA AT WILMINGTON
`1997 RAZOR WALKER AWARD FOR MEDICINE
`
`WINSTON SALEM STATE UNIVERSITY ALUMNI, WILMINGTON CHAPTER
`1997 COMMUNITY SERVICE AWARD
`
`NEW HANOVER COUNTY BOARD OF EDUCATION
`1995 CERTIFICATE OF RECOGNITION -- FOUNDED THIS PROGRAM TO RECOGNIZE HIGH ACHIEVING
`YOUNG BLACK MALES FROM FIVE SOUTHEASTERN NORTH CAROLINA COUNTIES
`
`SOUTHERN REGIONAL AHEC (formerly known as FAHEC) FAMILY PRACTICE RESIDENTS AWARDS
`1988-89 COMMUNITY PRECEPTOR OF THE YEAR
`1985-86 WARD SERVICE TEACHER OF THE YEAR
`
`ABBOTT Exhibit 2014, Page 5 of 11
`Dexcom, Inc. v. Abbott Diabetes Care Inc.
`IPR2023-01251
`
`

`

`PUBLICATIONS
`
`Eugene E. Wright Jr. and Savitha Subramanian.
`Is Continuous Glucose Monitoring a Tool, an Intervention, or Both?.
`Diabetes Technology & Therapeutics.Jun 2023.S-48-S-55.http://doi.org/10.1089/
`dia.2023.0025
`Michael Rickson, Eugene E. Wright Jr., Anila Bindal, and Laith Ghonim.
`Advancements in Diabetes Technology Are Outpacing the Evidence.
`Diabetes Technology & Therapeutics.Jun 2023.S-35-S-41.http://doi.org/10.1089/
`dia.2023.0145
`
`Kelepouris, E., St. Peter, W., Neumiller, J.J. et al. Optimizing Multidisciplinary Care of
`Patients with Chronic Kidney Disease and Type 2 Diabetes Mellitus. Diabetes Ther
`(2023). https://doi.org/10.1007/s13300-023-01416-2
`
`Rozalina G. McCoy, Eugene E. Wright, Piek Tan; Empowering Primary Care Practition-
`ers to Lead in Diabetes Care and Management. Clin Diabetes 1 July 2023; 41 (3): 435–
`437.
`Stephen Brunton, Steven Fishbane, Jennifer D. Goldman, Eugene Wright (2023) Ane-
`mia in CKD in Primary Care: Executive Summary. Clin Diabetes 2023;41(1):81–84
`https://doi.org/10.2337/cd22-0054
`Andrea M. Yeung, Jingtong Huang, Ambarish Pandey, Ibrahim A. Hashim, David Kerr,
`Rodica Pop-Busui, Connie M. Rhee, Viral N. Shah, Lia Bally, Antoni Bayes-Genis, Yong
`Mong Bee, Richard Bergenstal, Javed Butler, G. Alexander Fleming, Gregory Gilbert,
`Stephen J. Greene, Mikhail N. Kosiborod, Lawrence A. Leiter, Boris Mankovsky,
`Thomas W. Martens, Chantal Mathieu, Viswanathan Mohan, Kershaw V. Patel, Anne Peters,
`Eun-Jung Rhee, Giuseppe M.C. Rosano, David B. Sacks, Yader Sandoval, Jane Jeffrie Seley, Oliver
`Schnell, Guillermo Umpierrez, Kayo Waki, Eugene E. Wright, Alan H.B. Wu, David C. Klonoff,
`Biomarkers for the Diagnosis of Heart Failure in People with Diabetes: A Consensus Report from
`Diabetes Technology Society, Progress in Cardiovascular Diseases, Volume 79, 2023,
`Pages 65-79, ISSN 0033-0620, h3ps://doi.org/10.1016/j.pcad.2023.05.002.
`
`Yehuda Handelsman, Javed Butler, George L. Bakris, Ralph A. DeFronzo, Gregg C. Fonarow, Jen-
`nifer B. Green, George Grunberger, James L. Januzzi, Samuel Klein, Pamela R. Kushner, Darren K.
`McGuire, Erin D. Michos, Javier Morales, Richard E. Pratley, Ma3hew R. Weir, Eugene Wright,
`Vivian A. Fonseca, Early intervenLon and intensive management of paLents with diabetes, car-
`diorenal, and metabolic diseases, Journal of Diabetes and its ComplicaLons, 2023,
`108389, ISSN 1056-8727, h3ps://doi.org/10.1016/j.jdiacomp.2022.108389.
`
`Nicholas SB, Wright EE, Billings LK, Ambriz E, Gee P, Peeler T. Living with Chronic Kidney Disease
`and Type 2 Diabetes Mellitus: The PaLent and Clinician PerspecLve. Adv Ther. 2022 Oct 25:1–
`18. doi: 10.1007/s12325-022-02325-9. Epub ahead of print. PMID: 36282450; PMCID: PM-
`C9592880.
`
`ABBOTT Exhibit 2014, Page 6 of 11
`Dexcom, Inc. v. Abbott Diabetes Care Inc.
`IPR2023-01251
`
`

`

`Wong, V.W.-S., Zelber-Sagi, S., Cusi, K., Carrieri, P., Wright, E., Crespo, J. and Lazarus, J.V. (2022),
`Review arLcle Management of NAFLD in primary care sedngs. Liver Int. Accepted Author Man-
`uscript. h3ps://doi.org/10.1111/liv.15404
`
`Eugene E Wright Jr, Daniel C Malone, Jennifer M Trujillo, Jasvinder Gill, Samuel Huse, Xuan Li,
`Fang Liz Zhou, Ron Preblick, and Timothy Reid, Real-world persistence, adherence, health care
`resource uJlizaJon, and costs in people with type 2 diabetes switching from a first-generaJon
`basal insulin to a second-generaJon (insulin glargine 300 U/mL) vs an alternaJve first-genera-
`Jon basal insulin
`J Manag Care Spec Pharm, 2022 Mar. h3ps://doi.org/10.18553/jmcp.2022.21436
`
`Klonoff DC, Wang J, Rodbard D, et al. A Glycemia Risk Index (GRI) of Hypoglycemia and Hyper-
`glycemia for ConLnuous Glucose Monitoring Validated by Clinician RaLngs. Journal of Diabetes
`Science and Technology. March 2022. doi:10.1177/19322968221085273
`
`Jay H. Shubrook, Joshua J. Neumiller, Eugene Wright, Management of chronic kidney disease
`in type 2 diabetes: screening, diagnosis and treatment goals and recommendations,
`November 2021Postgraduate Medicine, https://doi.org/
`10.1080/00325481.2021.2009726
`
`Eden Miller, DO, Ma3hew S. D. Kerr, PhD, Gregory J. Roberts, BS, Yelena Nabutovsky, MS, Eu-
`gene Wright, MD Flash CGM Associated With Event ReducLon in Nonintensive Diabetes Therapy
`Am J Manag Care. 2021;27(11):e372-e377. h3ps://doi.org/10.37765/ajmc.2021.88780
`
`Bailey T, Evenou P, Gill J, Berhanu P, Raymond R, Strong J, Wright E. Post Hoc Analysis EvaluaLng
`the Impact of AnLhyperglycemic Background Therapies on A3ainment of A1C Targets Without
`Hypoglycemia in the ACHIEVE Control PragmaLc, Real-Life Study. Diabetes Spectr.
`2021;34(4):407-418.
`
`Fasiha Kanwal, Jay H. Shubrook, Leon A. Adams, Kim Pfotenhauer, Vincent Wai-Sun Wong, Eu-
`gene Wright, Manal F. Abdelmalek, Stephen A. Harrison, Rohit Loomba, Christos S. Mantzoros,
`Elisabe3a Bugianesi, Robert H. Eckel, Lee M. Kaplan, Hashem B. El-Serag, Kenneth Cusi,
`Clinical Care Pathway for the Risk StraLficaLon and Management of PaLents With Nonalcoholic
`Fa3y Liver Disease, Gastroenterology, 2021,ISSN 0016-5085,
`h3ps://doi.org/10.1053/j.gastro.2021.07.049.
`
`Wright EE, Subramanian S. Evolving Use of ConLnuous Glucose Monitoring Beyond Intensive
`Insulin Treatment. Diabetes Technol Ther. 2021 Sep;23(S3):S12-S18. doi: 10.1089/
`dia.2021.0191. PMID: 34546082.
`
`Eugene E. Wright, Ma3hew S.D. Kerr, Ignacio J. Reyes, Yelena Nabutovsky, Eden Miller
`
`ABBOTT Exhibit 2014, Page 7 of 11
`Dexcom, Inc. v. Abbott Diabetes Care Inc.
`IPR2023-01251
`
`

`

`Use of Flash ConLnuous Glucose Monitoring Is Associated With A1C ReducLon in People With
`Type 2 Diabetes Treated With Basal Insulin or Noninsulin Therapy Diabetes Spectrum 2021 Feb;
`ds200069.h3ps://doi.org/10.2337/ds20-0069
`
`Wright EE Jr., Morgan K, Fu DK, Wilkins N, Guffey WJ. Time in range: how to measure it, how to
`report it, and its pracLcal applicaLon in clinical decision-making. Clinical Diabetes 2020;38:439–
`448 (doi: 10.2337/cd20-0042)
`
`Wright EE Jr, Aroda VR. Clinical review of the efficacy and safety of oral semagluLde in paLents
`with type 2 diabetes considered for injectable GLP-1 receptor agonist therapy or currently on
`insulin therapy. Postgrad Med. 2020 Aug 20. doi: 10.1080/00325481.2020.1798127. Online
`ahead of print. PMID: 32815423
`
`
`Brunton SA, Mosenzon O, Wright EE Jr.
`IntegraLng oral semagluLde into clinical pracLce in primary care: for whom, when, and how?
`Postgrad Med. 2020 Aug 20. doi: 10.1080/00325481.2020.1798162. Online ahead of print.
`PMID: 32815453
`
`Irl B Hirsch, Ra3an Juneja, John M Beals, Caryl J Antalis, Eugene E Wright, Jr, The EvoluLon of
`Insulin and How it Informs Therapy and Treatment Choices, Endocrine Reviews,Volume 41, Issue
`5, October 2020, Pages 733–755, h3ps://doi.org/10.1210/endrev/bnaa015
`
`Ajjan, R., Sla3ery, D. & Wright, E. ConLnuous Glucose Monitoring: A Brief Review for Primary
`Care PracLLoners. Adv Ther 36, 579–596 (2019). h3ps://doi.org/10.1007/s12325-019-0870-x
`
`Hirsch IB, Wright EE Using Flash Glucose Monitoring in Primary PracLce
`Clinical Diabetes Vol 37, November 2, Spring 2019 (pp 150-161)
`
`Midye3 LK, Unger JR, Wright EE, Daniel, TD, Kruger, DF, Henry, RR, Hegazi, RA
`A Pilot Study to Assess Clinical ULlity and User Experience of Professional ConLnuous Glucose
`Monitoring Among People With Type 2 Diabetes
`Clinical Diabetes Vol. 37 No. 1 57-64
`
`Wright EE, Gavin JR Clinical Use of Professional ConLnuous Glucose Monitoring
`Diab Tech & Ther Vol 19 Supplemnt 2, 2017, pp S12-S15
`
`Wright EE, Blevins TC, Reed B, Pollom RD DemysLfying the Differences: Follow-on Biologics,
`Biosimilars and Generics
`Supplement to the JFP, 2017, April Vol 66 No 4
`
`Anderson JE, Wright EE Jr, Shaefer CF Jr.
`Empagliflozin: Role in Treatment OpLons for PaLents with Type 2 Diabetes Mellitus.
`Diabetes Ther. 2017 Feb;8(1):33-53.
`PMID: 27837465
`
`ABBOTT Exhibit 2014, Page 8 of 11
`Dexcom, Inc. v. Abbott Diabetes Care Inc.
`IPR2023-01251
`
`

`

`Singh, S., Wright, E. E., Kwan, A. Y., Thompson, J. C., Syed, I. A., Korol, E. E., Waser, N. A., Yu, M.
`B. and Juneja, R. (2016), Glucagon-like pepLde-1 receptor agonists compared with basal insulins
`for the treatment of type 2 diabetes mellitus: a systemaLc review and meta-analysis. Diabetes
`Obes Metab. Accepted Author Manuscript. doi:10.1111/dom.12805
`
`Wright, EE Jr., Manivannan, Sandhya
`Hot Topics in Primary Care: Ambulatory Glucose Profiling J Fam Pract. Dec 2015;64(suppl):S44-
`S47
`
`Wright, EE Jr.
`Results of the Epidemiology of Diabetes IntervenLons and ComplicaLons Trial
`Clinical Diabetes July 2015 vol. 33 no. 3 144-145
`
`Wright, EE, Stonehouse a, Cuddihy, RM
`In support of an early polypharmacy approach to the treatment of type 2 diabetes. November
`2010Diabetes Obesity and Metabolism 12(11):929-40 DOI: 10.1111/j.1463-1326.2010.01255.x
`
`Bell TJ, Wright EE Jr.
`Can Therapies That Target the IncreLn System Improve Our Ability to treat Type 2 Diabetes? J
`Natl Med Assoc. June 2010 Vol. 102 NO. 6 (pp 511-523)
`
`Wright EE Jr., Pollom RD, White RD, Kuritsky L
`PracLcal Strategies for Type 2 Diabetes in Primary Care. J Fam Pract. Aug 2009;58(suppl):S1-S32
`
`WRIGHT E, SCISM-BACON J, GLASS L
`OXIDATIVE STRESS IN TYPE 2 DIABETES: THE ROLE OF FASTING AND POSTPRADIAL GLYCAEMIA IN-
`TERNATIONAL JOURNAL OF CLINICAL PRACTICE
`March 2006, 60, 3, pp. 308-314
`
`HIRSCH IB, BERGENSTAL RB, PARKIN CG, WRIGHT E, BUSE JB
`A REAL WORLD APPROACH TO INSULIN THERAPY IN PRIMARY CARE
`CLINICAL DIABETES, Vol. 23, Number 2, 2005 (pp.78-86)
`
`WRIGHT EE, FELDMAN JM
`PANCREATIC ISLETS: A TISSUE RICH IN SEROTONIN DIABETES, Volume (4) April 29, 1980 (pp. 304-308)
`
`WRIGHT EE, BIRD JL, FELDMAN JMTHE EFFECTS OF HARMINE AND OTHER MONOAMINE OXIDASE IN-
`HIBITORS ON N-ACETYL TRANSFERASE ACTIVITY
`RESEARCH COMMUNICATIONS IN CHEM PATHOLOGY AND
`PHARMACOLOGY, Volume (2), May 24, 1979 (pp.259-272)
`
`
`E. E. Wright, E. Huang, M. Nada 82nd Annual ADA ScienLfic Sessions June 2022
`
`SELECTED PRESENTATIONS
`
`ABBOTT Exhibit 2014, Page 9 of 11
`Dexcom, Inc. v. Abbott Diabetes Care Inc.
`IPR2023-01251
`
`

`

`73-LB: Ambulatory Glucose Profile Informs Be3er Treatment Decisions for Type 2 Basal-Insulin
`PaLents.
`
`E. E. Wright, Jr., M. T. Novak, G. Hayter, N. Virdi, 82nd Annual ADA ScienLfic Sessions June 2022
`79-LB: The Effects of Glucose ReporLng Tools on TherapeuLc Decision Making- A ComparaLve
`Reading Study with Primary Care Providers (Also presented at the AFP, AANP, and AAPA annual
`meeLngs)
`
`Eugene E. Wright, Jr. MD, Medical Grand Rounds University of Illinois at Chicago, Oct. 5, 2021,
`Can Technology Inform BeWer Treatment Decisions In T2D?
`
`E. Wright, J. Gill, S. Huse, X. Li, T. Reid, F. L. Zhou Real-world persistence, adherence, healthcare
`resource uLlisaLon, and costs in people with type 2 diabetes switching from basal insulin (BI) to
`2nd- vs 1st-generaLon BI" Oral PresentaLon for the 57th EASD Annual MeeLng 27 September - 1
`October, 2021.
`
`E Miller, L Brandner, E Wright. HbA1c reducLon azer iniLaLon of the FreeStyle Libre system in
`type 2 diabetes paLents on long-acLng insulin or non-insulin therapy. Poster presented at:
`American Diabetes AssociaLon 80th ScienLfic Session; June 12-16, 2020; Virtual.
`
`
` E
`
` Wright, MSD Kerr, I Reyes, Y Nabutovsky, E Miller. A1c reducLon associated with FreeStyle Li-
`bre system in people with type 2 diabetes not on bolus insulin therapy. Poster presented at:
`American Diabetes AssociaLon 80th ScienLfic Session; June 12-16, 2020; Virtual.
`
`
` E
`
` Miller, MSD Kerr, GJ Roberts, D Souto, Y Nabutovsky, E Wright. FreeStyle Libre system use as-
`sociated with reducLon in acute diabetes events and all-cause hospitalizaLons in paLents with
`type 2 diabetes without bolus insulin. Poster presented at: American Diabetes AssociaLon
`80th ScienLfic Session; June 12-16, 2020; Virtual.
`
`PresentaLon at the Diabetes Is Primary conference of the 79th ADA ScienLfic Sessions San Fran-
`cisco, Ca June 2019 PaJent-Centered Care: What This Means for HCPs
`
`PresentaLon at the Diabetes Technology Society MeeLng, CGM in Type 2 Diabetes,
`November 2, 2017 Bethesda, Md.
`
`PresentaLon for the Duke SRAHEC Noon Resident / Faculty Conference; Treatment of Type 2 Di-
`abetes:
`Is our Current ClassicaJon and treatment Sufficient? ; Septemeber 1, 2017 Faye3eville, NC
`
`Poster PresentaLon at the 77th ADA ScienLfic Sessions Efficacy and Safety of DulagluJde in
`Black/African Americans with Type 2 Diabetes: A Subgroup Analysis June 11, 2017 SanDiego, CA
`
`Product Theater at the PriMed East Boston, Mass Dec. 2016 Product Theater on Jardiance CV
`Outcome Trial.
`
`ABBOTT Exhibit 2014, Page 10 of 11
`Dexcom, Inc. v. Abbott Diabetes Care Inc.
`IPR2023-01251
`
`

`

`Product Theater at the PriMed East Boston, Mass Dec. 2016 Product Theater on Basaglar and
`Follow On Biologics.
`
`Product Theater at the AADE16 Sessions, San Diego, Ca Product Theater on Basaglar and Fol-
`low On Biologics.
`
`Presentation at the 76th ADA Annual Scientific Sessions Corporate Symposium on “Two Years
`Of Flash Glucose Monitoring Recent Trial and the Global Clinical Experience” June 12, 2016
`New Orleans, La.
`
`Presentation at the National Association of Managed Care Physicians (NAMCP) “Improved Dia-
`betes Care with Ambulatory Glucose Profiling (AGP)” April 22, 2016 Orlando, Florida
`
`Panelist at the World Diabetes Congress of the International Diabetes Federation (IDF) Satellite
`Symposium “Getting to the Heart of Cardiovascular Risk in People with Type 2 Diabetes”
`November 30, 2015 Vancouver, British Columbia
`
`Chair of a Satellite Symposium on Ambulatory Glucose Monitoring at the 30th Annual Clinical
`Conference of the ADA May 23, 2015
`
`Workshop “Numeracy & Literacy: How Do You Do That With The PaLent In Front Of You?” 30th
`Clinical Conference of the ADA May 23, 2015
`
`PresentaLon “Pharmacologic Management of Type 2 Diabetes: Is Me}ormin All There Is?”
`100th Annual MeeLng of the American College of Physicians April 30, 2015
`
`Workshop “Diabetes and Aging: Barriers to Self Care” Clinical Conference of the ADA May 24,
`2014
`
`Workshop “Affordable Treatment for Diabetes for Uninsured and Underinsured” Clinical Confer-
`ence of the ADA May 24, 2013
`
`Keynote “Treatment Goals and Strategies to Prevent CompilaLons” Clinical Conference of the
`ADA May 23, 2013
`
`Keynote “Cardiometabolic Risk Assessment and Treatment Strategies” Clinical Conference of the
`ADA May 24, 2012
`
`Keynote and Workshop on “TransiLon from Hospital to Home” Clinical Conference of the ADA
`May 29, 2010
`
`ABBOTT Exhibit 2014, Page 11 of 11
`Dexcom, Inc. v. Abbott Diabetes Care Inc.
`IPR2023-01251
`
`